Hence, these in vivo results confirm the potential role of FBXO9 as an inhibitory protein against the migration, tumor sphere growth, and metastasis of lung cancer cells by promoting ATP6V1A ubiquitination. Here, ATP6V1A is linked to lung carcinoma.